Objective
The objective of the cross-cutting theme is to reduce the burden of preventable maternal and newborn deaths and illnesses in The Gambia and the sub region. This is a priority due to the current high mortality rates. If The Gambia continues this trajectory, it will miss the maternal and neonatal health SDG targets.
Cross-cutting and innovative research
The maternal and newborn health (MNH) research conducted at MRCG at LSHTM covers all three research themes within the Unit. This research relies on interdisciplinary collaboration, utilising the collective expertise of researchers from different approaches to advance knowledge in various domains. These include systems biology and immunology, observational and exploratory studies, large-scale clinical trials, implementation science, and health systems research.
The integration of diverse perspectives, methodologies, and approaches facilitates a comprehensive view across the continuum of care, extending from pregnancy and childbirth to the early days of infancy, with ongoing follow-up into the early years of life. This inclusive approach enriches our understanding of maternal and newborn health and strengthens our capacity and resources, supported by robust local and international partnerships.
Current research
Our current research portfolio encompasses a wide range of areas within MNH, including:
- Maternal and newborn and vaccine trials and immunological studies
- Efforts to reduce maternal and newborn infection morbidity and mortality.
- Examination of the impact of climate change on maternal health, pregnancy, and newborn outcomes
- Studies focusing on maternal and newborn outcomes following healthy and complicated pregnancies.
- Surveillance of vaccine safety during pregnancy
- Implementation and management of an Electronic Pregnancy Registry
Furthermore, we are expanding our research scope to incorporate other national and regional priority areas within MNH, aligning our efforts with the evolving needs and challenges in this critical field.